On Monday, July 9, President Obama signed the FDA bill which, in May, passed the House and Senate with ease. With this bill being made into law, PDUFA is authorized for a fifth time (PDUFA V) and generic companies, which were previously exempt, are now responsible for user fees.
To read more on this topic, check out these articles: GEN, Bloomberg BNA, and in-Pharma.